Not Signed In - Main Topic Area
All Topic Areas
1 - 10 of 45 more >>
Clinical Trials
1 - 5 of 12 more >>
- Study of DOXIL/CAELYX and VELCADE or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00103506 - Active, not recruiting
Multiple Myeloma
- A Study of Docetaxel Monotherapy or DOXIL®/CAELYX® and Docetaxel in Patients with Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00091442 - Active, not recruiting
Cancer of Breast
- Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00170573 - Active, not recruiting
Ovarian Cancer
- Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse
ClinicalTrials.gov Identifier: NCT00189553 - Active, not recruiting
Ovarian Cancer; Fallopian Tube Cancer
- Maintenance Treatment with Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients.
ClinicalTrials.gov Identifier: NCT00128778 - Completed
Breast Neoplasms
email this page
print this page
bookmark this page
feedback on this page
